The laboratory at Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB is designated as the institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines within the United Kingdom in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, as amended from time to time.]
Textual Amendments
F1Art. 1 substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(2); 2020 c. 1, Sch. 5 para. 1(1)
The duties of the laboratory referred to in Article 1 are set out in Annex II.
1.On the basis of a favourable result of the appraisal of an applicant laboratory in a [F3part of Great Britain, any relevant competent authority] may authorise the applicant laboratory to carry out the serological tests to monitor the effectiveness of rabies vaccines.
[F4 The Secretary of State, with the consent of the Welsh Ministers and the Scottish Ministers must draw up, keep up to date and publish a list of those laboratories that have been so authorised.]
2.On the basis of a favourable result of the appraisal of an applicant laboratory in a third country F5..., and following an application for approval from the competent authority of the third country of origin of the applicant laboratory, such laboratory shall be authorised F6... to carry out serological tests to monitor the effectiveness of rabies vaccines.
2A.[F7In this Article and in Annex 2—
(a)“the relevant competent authorities” means—
(i)in relation to England, the Secretary of State;
(ii)in relation to Scotland, the Scottish Ministers;
(iii)in relation to Wales, the Welsh Ministers;
(b)“third country” means any country other than the United Kingdom.]
F83.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .]
Textual Amendments
F2Substituted by Council Directive 2008/73/EC of 15 July 2008 simplifying procedures of listing and publishing information in the veterinary and zootechnical fields and amending Directives 64/432/EEC, 77/504/EEC, 88/407/EEC, 88/661/EEC, 89/361/EEC, 89/556/EEC, 90/426/EEC, 90/427/EEC, 90/428/EEC, 90/429/EEC, 90/539/EEC, 91/68/EEC, 91/496/EEC, 92/35/EEC, 92/65/EEC, 92/66/EEC, 92/119/EEC, 94/28/EC, 2000/75/EC, Decision 2000/258/EC and Directives 2001/89/EC, 2002/60/EC and 2005/94/EC (Text with EEA relevance).
F3Words in Art. 3(1) substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(a) (as amended by S.I. 2020/1388, regs. 1(2)(a), 25(2)(a)); 2020 c. 1, Sch. 5 para. 1(1)
F4Words in Art. 3(1) substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(b) (as amended by S.I. 2020/1388, regs. 1(2)(a), 25(2)(b)); 2020 c. 1, Sch. 5 para. 1(1)
F5Words in Art. 3(2) omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(c)(i); 2020 c. 1, Sch. 5 para. 1(1)
F6Words in Art. 3(2) omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(c)(ii); 2020 c. 1, Sch. 5 para. 1(1)
F7Art. 3(2A) inserted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(d) (as amended by S.I. 2020/1388, regs. 1(2)(a), 25(2)(c)) ; 2020 c. 1, Sch. 5 para. 1(1)
F8Art. 3(3) omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(3)(e); 2020 c. 1, Sch. 5 para. 1(1)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F9Art. 4 omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(4); 2020 c. 1, Sch. 5 para. 1(1)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F10Art. 5 omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(4); 2020 c. 1, Sch. 5 para. 1(1)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F12Art. 6 omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 5(4); 2020 c. 1, Sch. 5 para. 1(1)